PMID- 32915230 OWN - NLM STAT- MEDLINE DCOM- 20210329 LR - 20210329 IS - 1573-4935 (Electronic) IS - 0144-8463 (Print) IS - 0144-8463 (Linking) VI - 40 IP - 9 DP - 2020 Sep 30 TI - Emodin protects against intestinal and lung injury induced by acute intestinal injury by modulating SP-A and TLR4/NF-kappaB pathway. LID - 10.1042/BSR20201605 [doi] LID - BSR20201605 AB - OBJECTIVE: Our aim was to investigate the effect of emodin on intestinal and lung injury induced by acute intestinal injury in rats and explore potential molecular mechanisms. METHODS: Healthy male Sprague-Dawley (SD) rats were randomly divided into five groups (n=10, each group): normal group; saline group; acute intestinal injury model group; model + emodin group; model+NF-kappaB inhibitor pynolidine dithiocarbamate (PDTC) group. Histopathological changes in intestine/lung tissues were observed by Hematoxylin and Eosin (H&E) and terminal deoxynucleotidyl transferase biotin-dUTP nick-end labeling (TUNEL) staining. Serum IKBalpha, p-IKBalpha, surfactant protein-A (SP-A) and toll-like receptor 4 (TLR4) levels were examined using enzyme-linked immunosorbent assay (ELISA). RT-qPCR was performed to detect the mRNA expression levels of IKBalpha, SP-A and TLR4 in intestine/lung tissues. Furthermore, the protein expression levels of IKBalpha, p-IKBalpha, SP-A and TLR4 were detected by Western blot. RESULTS: The pathological injury of intestinal/lung tissues was remarkedly ameliorated in models treated with emodin and PDTC. Furthermore, the intestinal/lung injury scores were significantly decreased after emodin or PDTC treatment. TUNEL results showed that both emodin and PDTC treatment distinctly attenuated the apoptosis of intestine/lung tissues induced by acute intestinal injury. At the mRNA level, emodin significantly increased the expression levels of SP-A and decreased the expression levels of IKBalpha and TLR4 in intestine/lung tissues. According to ELISA and Western blot, emodin remarkedly inhibited the expression of p-IKBalpha protein and elevated the expression of SP-A and TLR4 in serum and intestine/lung tissues induced by acute intestinal injury. CONCLUSION: Our findings suggested that emodin could protect against intestinal and lung injury induced by acute intestinal injury by modulating SP-A and TLR4/NF-kappaB pathway. CI - (c) 2020 The Author(s). FAU - Qian, Jingli AU - Qian J AD - Department of Respiration, The Second Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou 310005, Zhejiang, China. FAU - Li, Guoping AU - Li G AD - Department of Respiration, Tongde Hospital of Zhejiang Province, Hangzhou 310012, Zhejiang, China. FAU - Jin, Xiaosheng AU - Jin X AD - Department of Respiration, Tongde Hospital of Zhejiang Province, Hangzhou 310012, Zhejiang, China. FAU - Ma, Chunfang AU - Ma C AD - Clinical Laboratory, Zhejiang Provincial People's Hospital, Hangzhou 310014, Zhejiang, China. FAU - Cai, Wanru AU - Cai W AD - Department of Respiration, The Second Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou 310005, Zhejiang, China. FAU - Jiang, Na AU - Jiang N AD - Department of Respiration, Tongde Hospital of Zhejiang Province, Hangzhou 310012, Zhejiang, China. FAU - Zheng, Jisheng AU - Zheng J AD - Department of Respiration, Tongde Hospital of Zhejiang Province, Hangzhou 310012, Zhejiang, China. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - England TA - Biosci Rep JT - Bioscience reports JID - 8102797 RN - 0 (NF-kappa B) RN - 0 (Pulmonary Surfactant-Associated Protein A) RN - 0 (Pyrrolidines) RN - 0 (Thiocarbamates) RN - 0 (Tlr4 protein, rat) RN - 0 (Toll-Like Receptor 4) RN - 25769-03-3 (pyrrolidine dithiocarbamic acid) RN - KA46RNI6HN (Emodin) RN - Q40Q9N063P (Acetic Acid) SB - IM MH - Acetic Acid/administration & dosage/toxicity MH - Acute Lung Injury/etiology/pathology/*prevention & control MH - Animals MH - Colon/blood supply/*drug effects/pathology MH - Disease Models, Animal MH - Emodin/*administration & dosage MH - Humans MH - Intestinal Mucosa/blood supply/*drug effects/pathology MH - Ischemia/chemically induced/complications/*drug therapy MH - Lung/drug effects/pathology MH - Male MH - NF-kappa B/antagonists & inhibitors/metabolism MH - Pulmonary Surfactant-Associated Protein A/metabolism MH - Pyrrolidines/administration & dosage MH - Rats MH - Signal Transduction/drug effects MH - Thiocarbamates/administration & dosage MH - Toll-Like Receptor 4/metabolism PMC - PMC7517261 OTO - NOTNLM OT - acute intestinal injury OT - emodin OT - lung injury OT - surfactant protein-A OT - toll-like receptor 4 COIS- The authors declare that there are no competing interests associated with the manuscript. EDAT- 2020/09/12 06:00 MHDA- 2021/03/30 06:00 PMCR- 2020/09/24 CRDT- 2020/09/11 12:12 PHST- 2020/05/30 00:00 [received] PHST- 2020/09/02 00:00 [revised] PHST- 2020/09/10 00:00 [accepted] PHST- 2020/09/12 06:00 [pubmed] PHST- 2021/03/30 06:00 [medline] PHST- 2020/09/11 12:12 [entrez] PHST- 2020/09/24 00:00 [pmc-release] AID - 226403 [pii] AID - BSR20201605 [pii] AID - 10.1042/BSR20201605 [doi] PST - ppublish SO - Biosci Rep. 2020 Sep 30;40(9):BSR20201605. doi: 10.1042/BSR20201605.